The invention relates to tumour therapy. In one aspect the present invention relates to conjugates of an amatoxin and a target binding moiety e.g. an antibody connected by a linker comprising a urea moiety which are useful in the treatment of cancer. In a further aspect the invention relates to pharmaceutical compositions comprising such conjugates.